Total planned funding: $288,274,743
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $73,036,038 |
Mozambique | $64,280,112 |
South Africa | $22,245,408 |
Kenya | $17,323,121 |
Zambia | $15,176,569 |
Democratic Republic of the Congo | $8,881,220 |
Vietnam | $8,879,314 |
India | $8,414,357 |
Côte d'Ivoire | $6,697,307 |
Papua New Guinea | $5,981,191 |
Botswana | $5,849,723 |
Burundi | $5,525,504 |
Tanzania | $5,452,881 |
Indonesia | $5,231,794 |
Uganda | $4,919,324 |
Angola | $4,716,719 |
Zimbabwe | $4,344,201 |
Asia Regional Program | $3,400,093 |
Malawi | $3,101,446 |
Eswatini | $2,847,187 |
Haiti | $2,616,452 |
Caribbean Region | $2,525,420 |
Cambodia | $2,025,000 |
Rwanda | $1,713,822 |
Ethiopia | $1,373,578 |
South Sudan | $566,962 |
Dominican Republic | $450,000 |
Namibia | $450,000 |
Lesotho | $250,000 |
Ghana | $0 |
Central Asia Region | $0 |
Organizational Types
NGO | $288,274,743 |
Program Areas
Care | $90,247,980 |
Treatment | $86,943,443 |
Prevention | $56,416,481 |
Testing | $27,839,946 |
Governance and Systems | $26,826,893 |
Budget Codes
HTXS: Treatment: Adult Treatment | $80,283,366 |
HKID: Care: Orphans and Vulnerable Children | $45,710,732 |
HVOP: Sexual Prevention: Other Sexual Prevention | $35,101,135 |
HBHC: Care: Adult Care and Support | $30,735,074 |
HVCT: Testing: HIV Testing and Counseling | $27,839,946 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $15,287,268 |
OHSS: Health Systems Strengthening | $9,601,852 |
HLAB: Laboratory Infrastructure | $9,091,474 |
HVSI: Strategic Information | $8,133,567 |
PDCS: Care: Pediatric Care and Support | $7,386,165 |
PDTX: Treatment: Pediatric Treatment | $6,660,077 |
HVTB: Care: TB/HIV | $6,416,009 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,231,113 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $1,455,067 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $582,093 |
HMBL: Biomedical Prevention: Blood Safety | $393,361 |
HMIN: Biomedical Prevention: Injection Safety | $366,444 |
HTXD: Treatment: ARV Drugs | $0 |